Clinical Trial Update: Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial of the gamma secretase inhibitor PF-03084014 for AIDS-related Kaposi sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Kaposi Sarcoma

Drugs mentioned

• PF-03084014 (nirogacestat)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: AIDS-related Kaposi Sarcoma, HIV Infection | Phase 2 | Status: WITHDRAWN